Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma
08/28/2015
Abstract: Transarterial ethanol ablation (TEA) has been compared to transarterial chemoembolization  (TACE) in randomized controlled trials and found to be associated with better tumor response in hepatocellular carcinoma (HCC). These...
Abstract: Transarterial ethanol ablation (TEA) has been compared to transarterial chemoembolization  (TACE) in randomized controlled trials and found to be associated with better tumor response in hepatocellular carcinoma (HCC). These...
Abstract: Transarterial ethanol...
08/28/2015
IO Learning
Clinical Insights
SIRFLOX Data Show Mixed Results for Survival
08/05/2015
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a...
08/05/2015
IO Learning
Clinical Insights
Andor van den Hoven, MD, Describes a Particle-Fluid Dynamics Study for Radioembolization of Colorectal Liver Metastases
07/28/2015
IO360: Please describe your facility, the makeup of the IO team, and the IO procedures done at your facility.van den Hoven: I am an MD working as a PhD candidate at the Department of Radiology and Nuclear Medicine of the University Medical...
IO360: Please describe your facility, the makeup of the IO team, and the IO procedures done at your facility.van den Hoven: I am an MD working as a PhD candidate at the Department of Radiology and Nuclear Medicine of the University Medical...
IO360: Please describe your...
07/28/2015
IO Learning
Clinical Insights
Cone-Beam Computed Tomography for Interventional Oncology: an Interview With Nishita Kothary, MD
07/18/2015
At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), SIR member Nishita Kothary, MD, FSIR, an interventional radiologist and associate professor of general radiology at Stanford University Medical Center,...
At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), SIR member Nishita Kothary, MD, FSIR, an interventional radiologist and associate professor of general radiology at Stanford University Medical Center,...
At the 2015 Annual Scientific...
07/18/2015
IO Learning
Clinical Insights
Management of Locoregional Recurrence of Rectal Cancer After Surgery Using Radiofrequency Ablation
07/17/2015
Abstract: The primary mode of treatment for rectal carcinoma is resection. Despite radical surgery, 10% to 25% of patients develop local recurrence, the majority of which involve pelvic sidewall or surrounding organs. Radiofrequency ablation...
Abstract: The primary mode of treatment for rectal carcinoma is resection. Despite radical surgery, 10% to 25% of patients develop local recurrence, the majority of which involve pelvic sidewall or surrounding organs. Radiofrequency ablation...
Abstract: The primary mode of...
07/17/2015
IO Learning
Clinical Insights
Comparing an Antireflux Catheter to Standard End-Hole Catheter for Y90 Treatment of HCC: An Interview With Alexander Pasciak, PhD
06/19/2015
Watch related video of this interview.Alexander Pasciak, PhD, is a physicist and researcher at the University of Tennessee Medical Center. At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), Dr. Pasciak,...
Watch related video of this interview.Alexander Pasciak, PhD, is a physicist and researcher at the University of Tennessee Medical Center. At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), Dr. Pasciak,...
Watch related video of this...
06/19/2015
IO Learning
Clinical Insights
Improving Cancer Care by Studying Tumor Vessel Formation
05/21/2015
John Haaga, MD, FSIR, is a tenured professor and emeritus chairman of the Department of Radiology at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center. He was invited to the 2015 Society of...
John Haaga, MD, FSIR, is a tenured professor and emeritus chairman of the Department of Radiology at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center. He was invited to the 2015 Society of...
John Haaga, MD, FSIR, is a...
05/21/2015
IO Learning
Clinical Insights
Cost Accounting for Transarterial Chemoembolization
05/08/2015
At the 2015 Society of Interventional Radiology Annual Scientific Meeting, Osman Ahmed, MD, and colleagues from Stanford University presented a poster titled “Cost Accounting as a Tool for Increasing Cost Transparency in...
At the 2015 Society of Interventional Radiology Annual Scientific Meeting, Osman Ahmed, MD, and colleagues from Stanford University presented a poster titled “Cost Accounting as a Tool for Increasing Cost Transparency in...
At the 2015 Society of...
05/08/2015
IO Learning
Clinical Insights
New Technologies in Interventional Oncology: An Interview With Erik Cressman, MD, PhD, FSIR
04/16/2015
The 2015 Society of Interventional Radiology Annual Scientific Meeting featured 26 sessions in its oncologic interventions educational pathway. Invited faculty included Erik Cressman, MD, PhD, FSIR, a physician scientist at MD Anderson...
The 2015 Society of Interventional Radiology Annual Scientific Meeting featured 26 sessions in its oncologic interventions educational pathway. Invited faculty included Erik Cressman, MD, PhD, FSIR, a physician scientist at MD Anderson...
The 2015 Society of...
04/16/2015
IO Learning
Clinical Insights
Carbon Dioxide Imaging in Interventional Oncology: Preserving Renal Function and Providing Potentially Lifesaving Procedures to Previously Precluded Patients
04/15/2015
Carbon dioxide has been used as an imaging contrast agent since the early 1900s. Its use has proliferated in a variety of clinical scenarios secondary to its unique properties combined with advancements in technology. Additionally, when used...
Carbon dioxide has been used as an imaging contrast agent since the early 1900s. Its use has proliferated in a variety of clinical scenarios secondary to its unique properties combined with advancements in technology. Additionally, when used...
Carbon dioxide has been used as...
04/15/2015
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement